Heart Failure and Cardiothoracic Transplant Biorepository

Overview

About this study

This study is being done to develop a serum and tissue bank for future research of patients with heart failure, mechanical circulatory support and/or cardiothoracic transplants. This blood/tissue will be used for three principle purposes: (1) laboratory tests which will be available in the future but that are not currently available and which may be of benefit to the patient, (2) review of previous patient laboratory results made necessary by development of a new disease process by the patient, and (3) future unspecified research purposes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Subject population - Cardiothoracic transplant patients (pretransplant and follow-up), heart failure patients and patients prior to and on mechanical circulatory support take part in this study.

  • Those who have signed informed consent. 

Exclusion Criteria: 

  • Those who have not signed informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Naveen Pereira, M.D.

Open for enrollment

Contact information:

Nong Braaten L.P.N.

Braaten.Nong@mayo.edu

More information

Publications

Publications are currently not available